Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Amarin Corp ADR (AMRN)

Amarin Corp ADR (AMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Amarin Plc (AMRN) Q1 2024 Earnings Call Transcript Motley Fool - Wed May 1, 10:00AM CDT

AMRN earnings call for the period ending March 31, 2024.

AMRN : 0.9700 (+6.59%)
New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups Newswire.ca - Mon Apr 8, 5:30AM CDT

/CNW/ - HLS Therapeutics Inc. (HLS or the Company) (TSX: HLS), a pharmaceutical company focusing on addressing unmet needs in the treatment of psychiatric...

AMRN : 0.9700 (+6.59%)
HLS.TO : 4.80 (+1.05%)
Why Amarin Stock Was Rocketing Higher on Wednesday Motley Fool - Wed Apr 3, 3:13PM CDT

There was unambigously good news about the company's single commercialized medication.

AMRN : 0.9700 (+6.59%)
Amarin Plc (AMRN) Q4 2023 Earnings Call Transcript Motley Fool - Thu Feb 29, 2:30PM CST

AMRN earnings call for the period ending December 31, 2023.

AMRN : 0.9700 (+6.59%)
Why Amarin Stock Skyrocketed Today Motley Fool - Wed Jan 10, 6:02PM CST

The biopharma company announced a big repurchase plan, along with strong preliminary Q4 results.

AMRN : 0.9700 (+6.59%)
Amarin Plc (AMRN) Q3 2023 Earnings Call Transcript Motley Fool - Wed Nov 1, 2023

AMRN earnings call for the period ending September 30, 2023.

AMRN : 0.9700 (+6.59%)
Why Amarin Stock Is Sinking Today Motley Fool - Wed Jul 19, 2023

The drugmaker announced a major corporate reorganization and a new CEO.

AMRN : 0.9700 (+6.59%)
Amarin Plc (AMRN) Q1 2023 Earnings Call Transcript Motley Fool - Wed May 3, 2023

AMRN earnings call for the period ending March 31, 2023.

AMRN : 0.9700 (+6.59%)
Amarin's (AMRN) Q1 Earnings Top, Vascepa Sales Fall Zacks - Wed May 3, 2023

Amarin's (AMRN) first-quarter 2023 earnings and revenues beat estimates. Vascepa sales decline.

AMRN : 0.9700 (+6.59%)
RCUS : 15.90 (+1.27%)
ALLO : 3.03 (-1.30%)
OCUP : 2.0500 (+3.02%)
Biotech/Drug Stocks' Q1 Earnings Due May 3: UTHR, PCRX & More Zacks - Tue May 2, 2023

Let us take a look at what's in store for biotech/drug stocks UTHR, PCRX, CORT, AMRN and IONS, which are scheduled to report on May 3.

UTHR : 259.38 (-1.15%)
PCRX : 26.82 (-1.43%)
AMRN : 0.9700 (+6.59%)
CORT : 23.27 (-5.10%)
IONS : 42.30 (+0.79%)

Barchart Exclusives

NVIDA Stock Is Still Undervalued, and Shorting Its Put Options Are Still are Great Income Play Barchart - 9 minutes ago
Nvidia stock still looks undervalued here, even though the stock keeps rising. This is based on higher analyst revenue and FCF estimates. This creates a good short-put play, especially for existing investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot